Subscribe for PTCOG-NA Updates
IBA is your worldwide innovation leader in the field of proton therapy with future technologies such as DynamicARC® and ConformalFLASH® on our Proteus® platform. Thanks to our innovative mindset, we have remained ahead of the curve and built the largest community of proton therapy users who have treated more than 120,000 patients globally. Together we form the most knowledgeable proton therapy community in the world. We are not mere providers, we are real partners. Learn more on Campus - Your Proton Therapy Community.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
Gold Anchor is a fiducial marker for soft tissue with proven clinical benefits. For proton therapy, Gold Anchor offers the following unique combination of benefits compared to alternatives:
Klarity is at the forefront of radiotherapy technology and innovation. Klarity’s superior products and personalized service have established the company as a worldwide leader, providing clinics with improved solutions for patient positioning, treatment planning, brachytherapy, and custom devices.
Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in proton therapy thanks to devices that perfectly pair with advanced proton therapy delivery techniques. Aerial®, an award-winning proton couch top, optimizes the impact on proton dose. Combined with Nanor® masks we provide greater patient comfort while ensuring stability and reproducibility.
RAD provides complex, design-built modular facilities for the healthcare industry. These customized, factory fabricated solutions are completed up to 50% faster than standard construction and are installed for temporary, interim or permanent use. Our facility solutions are rapidly deployable, can be relocatable and include radiotherapy vaults and clinics, proton centers, medical oncology facilities, sterile processing facilities and other specialty healthcare installations. Short term rentals are available as are unique financing options that require no capital.
C4 Imaging pioneers cutting-edge MRI-positive signal markers, revolutionizing precision treatment planning and cancer therapy. Their flagship innovation, NOVA, stands alone as the premier MRI-positive signal fiducial marker, delivering precise daily treatment alignment, reduced dose perturbation, and pinpoint tumor localization for focal therapy. In addition to NOVA, C4 Imaging introduces Sirius and Orion, MRI-positive signal markers that excel in seed localization for Low Dose Rate (LDR) treatment and meticulous radiation dose delivery for High Dose Rate (HDR) therapy. These groundbreaking markers empower clinicians to provide unparalleled precision and effectiveness in cancer treatment, enhancing patient care and outcomes.
Proton Collaborative Group (PCG) is committed to improving the outcomes of cancer patients by working collectively to advance the role of particle radiotherapy in cancer treatment. PCG serves as the link between state-of-the-art treatment centers, expert physicians, innovative and high-quality collaborative research, and the largest and most comprehensive proton therapy database in the world.